Product Images Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate NDC 66993-595 by Prasco Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - adderall 01

Figure 1 - adderall 01

The text describes mean plasma concentrations of Dextroamphetamine and Levamphetamine in ng/mL for different dosages at various intervals of time, represented in a graph. The dosages include MAS-ER 20 mg ad, ADDERALL® 10 mg bid, and T MAS-ER 20mg qd. The time intervals are shown in hours, ranging from 12 to 24.*

PRINCIPAL DISPLAY PANEL - 5 mg Capsule Bottle Label - adderall 02

PRINCIPAL DISPLAY PANEL - 5 mg Capsule Bottle Label - adderall 02

This is a medication called Dextroamphetamine Saccharate which is a mixture of different salts to produce an extended-release capsule used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. The medication guide must be dispensed by the pharmacist for the patient. There are 100 Capsules in a prescription.*

PRINCIPAL DISPLAY PANEL - 10 mg Capsule Bottle Label - adderall 03

PRINCIPAL DISPLAY PANEL - 10 mg Capsule Bottle Label - adderall 03

This is a medication description for a 10mg extended-release capsule containing Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. These active ingredients belong to the "Mixed Salts of A Single-Entity Amphetamine Product" category. The product contains 100 capsules and is available by prescription only. The pharmacist should refer to the attached E225 label for dispensing information.*

PRINCIPAL DISPLAY PANEL - 15 mg Capsule Bottle Label - adderall 04

PRINCIPAL DISPLAY PANEL - 15 mg Capsule Bottle Label - adderall 04

This is a description of a medication named NDC 66993-596.02. It includes information about the type of drug, its dose (5mg), and what it is used for (treating various conditions). The medication comes in a container that should be stored at room temperature, and there are detailed instructions included in the package insert. Pharmacies should dispense the medication with an attached medication guide. The manufacturer is Prasco, and the medication is only available with a prescription (Rx only).*

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Bottle Label - adderall 05

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Bottle Label - adderall 05

This is a medication with the NDC code 66093-597-02. It contains a combination of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. It is an Extended-Release capsule with a strength of 20mg. The medication guide is attached and should be dispensed with the medication. It should be stored at room temperature, and each capsule contains different strength of the constituents. The package insert should be consulted for complete information.*

PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle Label - adderall 06

PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle Label - adderall 06

This appears to be a prescription drug label for a medication with the brand name "DO G650". It is an extended-release capsule containing a combination of different salts of dextroamphetamine and amphetamine. The exact dosage is not mentioned, but it comes in both 25 mg and 100 capsule packages and is available only with a prescription (Rx only). The label also includes the name of a pharmaceutical company called PRASCO.*

PRINCIPAL DISPLAY PANEL - 30 mg Capsule Bottle Label - adderall 07

PRINCIPAL DISPLAY PANEL - 30 mg Capsule Bottle Label - adderall 07

This is a description of a prescription medication. The medication is a combination of different salts of amphetamine, including dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, and is designed as an extended-release capsule with a strength of 30 mg. The medication contains a medication guide and should be dispensed in a light-resistant container per USP guidelines. The total amount of amphetamine base equivalence is 18.8 mg per capsule. The medication is packaged with 100 capsules and is available only by prescription.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.